Please login to the form below

Not currently logged in
Email:
Password:

New accounts: May

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com

AstraZeneca

Faslodex

Breast cancer

The Medical Multimedia Company

Genzyme

Thyrogen

Oncology

Big Blue

Genzyme Therapeutics

Corporate

Corporate

Langland

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Intervet

Ibaflin gel

Antibiotic

Woolley Pau

Lilly

Corporate

Diabetes

PAN Advertising

Lilly

Humalog insulins and devices

Diabetes

PAN Advertising

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Roche

Avastin

Colorectal cancer

MJL Advertising

sanofi-aventis

Taxotere

Oncology

Medicus London

sanofi-aventis

Arava

Arthritis

Medicus London

sanofi-aventis

Targocid

Anti-infective

Medicus London

sanofi-aventis

Xatral

Benign prostatic hyperplasia

Medicus London

sanofi-aventis

Tavanic

Anti-infective

Medicus London

Schering-Plough

Subutex

Opioid dependence

Medicus London

Schering-Plough

Viraferon-Peg

Hepatitis C

Medicus London

Vernacare

Portfolio

Infection control

Mason Zimbler

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...